Topical natural-origin polynucleotides in radiation-induced skin and mucosal toxicity

Folia Med (Plovdiv). 2022 Oct 31;64(5):716-724. doi: 10.3897/folmed.64.e66980.

Abstract

Seventy to 90 percent of patients who have received radiation treatment struggle with radiation skin and mucosal toxicity. The inflicted damage to progenitor cells and local microcirculation makes it more likely that wounds, infections, and fibrosis may occur; lesions of variable severity often co-exist. Acute erythema, hyperpigmentation, and mild desquamation usually wane in weeks and require only minor treatment. Conversely, the management of persistent radiation dermatitis and telangiectasia remains unsatisfactory; chronic lesions may progress to tissue atrophy and disfiguring fibrosis.

Keywords: cancer radiotherapy polynucleotides radiation-induced skin reactions radiodermatitis.

MeSH terms

  • Atrophy
  • Humans
  • Polynucleotides*
  • Skin*

Substances

  • Polynucleotides